Andreas Tiede
Dec 21, 2025, 11:37
Acquired Hemophilia A Patients’ Immunosuppressants Careful Usage Shared by Andreas Tiede
Andreas Tiede, Professor, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation at Hannover Medical School, shared a post on LinkedIn:
“If you’re interested in Acquired Hemophilia A, read the thoughtful comments by Jerome Teitel and Jean St.-Louis about the more careful use of immunosuppressants in these fragile patients.”
Title: Deferral of immunosuppression in acquired hemophilia
Authors: Jerome Teitel, Jean St-Louis
Explore more posts from Andreas Tiede to deepen insights into hemostasis with Hemostasis Today.
-
May 8, 2026, 06:24Transforming Thrombosis Management With Antithrombotic Stewardship – Anticoagulation Forum
-
May 8, 2026, 06:03Risk-Stratified HRT Use Following VTE – NBCA
-
May 7, 2026, 17:56The Latest Clinical Data Shaping The Evolving Landscape of Hemophilia Treatment – EAHAD
-
May 7, 2026, 17:31Talha Badar: New Classical Hematology Chapter on Bleeding and Thrombosis
-
May 7, 2026, 17:26Maria Τektonidou: Gene Network Analysis Identifies STAT1 in Thrombotic APS
-
May 7, 2026, 17:23Sonu Bhaskar: Inflammatory Biomarkers in Acute Cerebral Venous Sinus Thrombosis
-
May 7, 2026, 16:53Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
-
May 7, 2026, 16:34Arun V J: Give Blood and Be the Hero You Always Wanted to Be
-
May 7, 2026, 16:15August Bones: When Would You Consider Placing an Inferior Vena Cava Filter After a Pulmonary Embolism?